Biological Information

Background Information:

Lysyl Oxidase Homolog 2 (LOXL2) is a member of lysyl oxidase-like (LOXL) gene family which includes LOXL1 through LOXL4. LOX catalyzes the crosslinking of extracellular matrix (ECM) such as collagen and elastin. LOXL2 is highly expressed in uterus and prostate. LOXL2 is also upregulated in many cancer cells, remodels tumor microenvironment as regulator of carcinogenesis. LOXL2 may serve as a potential therapeutic target against cancer.

Family:

Oxidoreductase

Sub Family:

Oxidase

Class:

Oxidase

Protein Name:

LOXL2

Uniprot Number:

Q9Y4K0

Protein Aliases:

Lysyl oxidase-like protein 2

Gene Name:

LOXL2

Gene ID:

4017

Gene Aliases:

WS9-14; LOR

Accession Number:

NM_002318

Organism:

Human

Construct Details:

Full length, Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Enzymatic

Functional Mode:

Antagonist

Detection Method:

Spectrofluorimetry

Measured Response:

Fluorescence

Testing Information

Procedure Summary:

Human recombinant LOXL2 enzyme expressed in mouse myeloma cells is used. Test compound and/or vehicle is preincubated with 4 µg/ml active enzyme in modified sodium borate buffer pH 8.0 for 15 minutes at 37°C. The reaction is initiated by addition of 300 uM cadaverine substrate and Amplex Ultrared for another 30 minute incubation period. Determination of the amount of resorufin formed is read spectrofluorimetrically at 544 nm/590 nm. Compounds are screened at 10 uM.

Substrate:

300 µM Cadavertine

Incubation:

30 min at 37°C

Control Inhibitor:

PXS-5153A

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uM

Test Sample Requirements:

Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).

Minimum Order Quantity:

2

Turnaround Time

Standard:

15 Business Days

Reference Compound Data

PubChem ID

145712358

Name

PXS-5153A

Measurement

0.028µM - IC50

Clinical Relevance

Therapeutic Area:

Inflammation/Allergy

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei

RELATED SOLUTIONS

Item: PP318